Work Ongoing To Develop Zika Vaccine; Scientists Report Creation Of Mouse Model To Aid Research

Nature: The race is on to develop Zika vaccine
“Public health officials say that the first human trials of a Zika vaccine could begin this year. But they caution that it will take until at least next year, and possibly much longer, to determine whether a vaccine works…” (Hayden, 3/28).

New York Times: Zika Study Could Help Overcome an Obstacle to Vaccine Research
“The first new mouse model in which the Zika virus can be tested was described in a medical journal on Monday…” (McNeil, 3/28).

Reuters: U.S. scientists develop mouse model to test Zika vaccines, drugs
“…Normally, creating this kind of mouse model would take several months. But the urgency of the Zika outbreak called for rapid response, and the team put together the results in just three weeks, said Shannan Rossi, a UTMB virologist who led the study…” (Steenhuysen, 3/28).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

The Henry J. Kaiser Family Foundation Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270 | Email Alerts: | |

Filling the need for trusted information on national health issues, the Kaiser Family Foundation is a nonprofit organization based in San Francisco, California.